Preoperative CA-125 Levels in Patients with Hereditary Compared to Sporadic Epithelial Ovarian Carcinoma

This publication has 14 references indexed in Scilit:

• Clinicopathologic Features of BRCA-Linked and Sporadic Ovarian Cancer
  JAMA, 2000
• The Ability of Preoperative Serum CA-125 to Predict Optimal Primary Tumor Cytoreduction in Stage III Epithelial Ovarian Carcinoma
  Gynecologic Oncology, 2000
• Comparison of Standard and CA-125 Response Criteria in Patients With Epithelial Ovarian Cancer Treated With Platinum or Paclitaxel
  Journal of Clinical Oncology, 1999
• Preoperative Determination of Several Serum Tumor Markers in Patients with Primary Epithelial Ovarian Carcinoma
  Gynecologic and Obstetric Investigation, 1999
• Preoperative Value of CA 125 as a Reflection of Tumor Grade in Epithelial Ovarian Cancer
  Gynecologic Oncology, 1996
• The CA 125 tumour-associated antigen: a review of the literature
  Human Reproduction, 1989
• The clinical significance of pre-operative serum CA 125 in ovarian cancer
  BJOG: An International Journal of Obstetrics and Gynaecology, 1987
• CA125 as a serum marker for poor prognosis in ovarian malignancies
  Gynecologic Oncology, 1987
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983
• Reactivity of a monoclonal antibody with human ovarian carcinoma.
  Journal of Clinical Investigation, 1981